1.Debenedictis TJ., Marmar ML., Praiss DE. Intraurethral condylomas acuminata: management and review of the literature. J Urol. 1977. 118:767–9.
Article
2.Bohle A., Doehn C., Kausch I., Jocham D. Treatment of recurrent penile condyloma acuminate with external application and intraurethral instillation of bacillus calmette-guerin. J Urol. 1998. 160:394–6.
3.Kim EK., Lee NK., Park YH. Detection of interleukin 2 in the urine of patients with superficial bladder tumors after intravesical BCG therapy. Korean J Urol. 1996. 37:1227–33.
4.Fralick RA., Malek RS., Goellner JR., Hyland KM. Urethroscopy and urethral cytology in men with external genital condyloma. Urology. 1994. 43:361–4.
Article
5.Simmons PD., Langlet F., Thin RN. Cryotherapy versus electrocautery in the treatment of genital warts. Br J Vener Dis. 1981. 57:273–4.
Article
6.Kim SG., Seo IY., Rim JS. Nd: YAG laser therapy for intraurethral condyloma acuminatum in men. Korean J Urol. 2003. 44:911–5.
7.Dretler SP., Klein LA. The eradication of intraurethral condyloma acuminata with 5 percent 5-fluorouracil cream. J Urol. 1975. 113:195–8.
8.Chopra V., Tyring SK. Suppression of interleukin-2 production and activity by factor (s) released by peripheral blood mononuclear cells during papillomavirus infections. Viral Immunol. 1991. 4:237–48.
9.Hamblin TJ. Long-lasting response of therapy-resistant viral warts to treatment with interleukin-2 in a patient with chronic lymphocytic leukemia (CLL) and profound immunodeficiency. Leuk Res. 2007. 31:413–4.
Article
10.Kreft ME., Sterle M., Veranic P., Jezernik K. Urothelial injuries and the early wound healing response: tight junctions and urothelial cytodifferentiation. Histochem Cell Biol. 2005. 123:529–39.
Article